Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a

Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, Marie A. D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L. A. Koppe, Marlies E. Nowee, Henrike Westerveld, Maria A. A. De Jong, Filip Frühauf, Jeltsje S. Cnossen, Jan Willem M. Mens, Jannet C. Beukema, Cyrus Chargari, Charles Gillham, Dorine S. J. Tseng, Katrien Vandecasteele, Karen Verhoeven-Adema, Hans W. Nijman, Remi A. Nout, Bastiaan G. Wortman, Stephanie M. De Boer, Hein Putter, Vincent T. H. B. M Smit, Carien L. Creutzber
British Journal of Cancer · Springer Nature · 2026-11-11 · DOI: 10.1038/s41416-026-03642-4

Abstract

British Journal of Cancer, Published online: 11 November 2026; doi:10.1038/s41416-026-03642-4 Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a

Read at publisher →

Similar articles